Skip to content

Clinical trials

Phase 1 Glioblastoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1 Country / region: Germany Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20111
20122
20131
20141
20151
20161
20171
20182
20211
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting3
Recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
European Organisation for Research and Treatment of Cancer - EORTC2
Amgen1
Celgene1
CureVac1
German Cancer Research Center1
Immatics Biotechnologies GmbH1
Johann Wolfgang Goethe University Hospital1
Nationwide Children's Hospital1
PD Dr. Martin Glas1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma18
Astrocytoma4
Glioma4
Breast Neoplasms2
Leukemia2
Oligodendroglioma2
Brain Neoplasms1
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Central Nervous System Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.